GENE ONLINE|News &
Opinion
Blog

Comprehensive Genomic Profiling
Foundation Medicine Enters Partnership With Epic to Integrate Genomic Insights into EMR Systems
2021-08-30
FoundationOne CDx Okayed as Companion Diagnostic for Takeda’s Lung Cancer Drug
2021-07-04
#ASCO21: Large Cohort Study by Foundation Medicine and Collaborators Reveal Disparities in Precision Cancer Care
2021-06-09
Top Announcements from the J.P. Morgan Healthcare Conference 2021
2021-01-13
Foundation Medicine’s Liquid Biopsy Test Bags FDA Approval for Eighth Indication as Companion Diagnostic
2020-11-10
Telix Pharma Partners With China Grand Pharma for Greater China Marketing
2020-11-05
Scorpion Therapeutics Scores $108 Million Series A Funding for Oncological Research
2020-10-28
OneOncology Enters First-of-its-Kind Partnership with FMI to Advance Personalized Medicine at Community Oncology Practices
2020-08-18
M&A
Foundation Medicine Fortifies Growing Prominence in Liquid Biopsy Space by Acquiring Lexent Bio
2020-06-15
FoundationOne®CDx Approved as Companion Diagnostic for Novartis’ Piqray
2019-12-09
Comprehensive Genomic Profiling at the Cusp of Modern Precision Oncology: Interview with Dr. Nicolas Martin 
2019-12-03
LATEST
Mechanisms of Allograft Rejection: Insights from Behind the Scenes
2024-04-25
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top